FSGS
Nephrology·MeSH: Female Urogenital Diseases
5 drugs in development·5 companies·2 clinical trials
Drug Pipeline by Phase
Approved(1)
Phase 3(1)
| Drug | Company |
|---|---|
| DMX-200 | AMICUS THERAPEUTICS, INC. (FOLD) |
Preclinical(1)
| Drug | Company |
|---|---|
| pcs499 | Processa Pharmaceuticals, Inc. (PCSA) |
BLA Filed(1)
| Drug | Company |
|---|---|
| FILSPARI | Travere Therapeutics, Inc. (TVTX) |
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| APL2 | Apellis Pharmaceuticals, Inc. (APLS) |
Compare drugs
Frequently asked questions
How many drugs are in development for FSGS?
BioSniper tracks 5 drugs in development for FSGS across 5 companies.
How many clinical trials target FSGS?
There are 2 clinical trials targeting FSGS tracked by BioSniper.
Deep-dive into FSGS
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis